John Fowler has been appointed chief operating officer Piramal Pharma Solutions (PPS). Mr. Fowler will be responsible for Global Operations and R&D, and will play a lead role in ensuring that our customers consistently experience differentiated and excellent levels of service.
 
Mr. Fowler most recently served as the Divisional chief executive officer of the Global Fine Chemicals business at Johnson Matthey, responsible for Services (Custom API Development, Manufacturing, Catalyst & Chiral Technologies), and Products (Generics Development and Manufacturing) portfolio. He also held senior leadership roles in several business areas at JM, including Pharmaceutical Materials and Services, Environmental Catalysts and Technologies, among others.
 
Vivek Sharma, chief executive officer, Piramal Pharma Solutions, said, “As PPS enters into the next phase of its rapid growth, it is important that we bring in seasoned executives with international experience and expertise. John’s track record of aligning services and talent towards a common vision, is one that the PPS team can benefit from. We are excited to have John as part of our Leadership team, welcome him, and look forward to his contributions in building strategic partnerships with our customers and propel PPS forward into the next decade.”